Skip to main content
OpenTrials

Clinical trial condition

Ovarian Diseases

Explore clinical trials studying Ovarian Diseases. Study availability and eligibility vary by location and protocol.

3,397 public trials 657 recruiting studies
Refine in advanced search Browse all conditions

Ovarian Diseases trial results

Active, Not Recruiting

Testing the Combination of Cediranib and Olaparib in Comparison to Each Drug Alone or Other Chemotherapy in Recurrent Platinum-Resistant Ovarian Cancer

NCT02502266

Conditions
Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +29 more
Locations
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • Alaska Women's Cancer Care Anchorage, Alaska, United States
  • Providence Alaska Medical Center Anchorage, Alaska, United States
  • University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
View all 398 locations
View Trial Details
Active, Not Recruiting

M9466 Alone or in Combination in Advanced Solid Tumors (DDriver 501)

NCT06421935

Conditions
Adnexal Diseases, Advanced Solid Tumor, Endocrine Gland Neoplasms, +13 more
Locations
  • NEXT Oncology - PARENT New York, United States
  • The University of Texas MD Anderson Cancer Center Houston, Texas, United States
  • Cancer Research SA Adelaide, Australia
  • GenesisCare North Shore (Oncology) St Leonards, Australia
View all 20 locations
View Trial Details
Active, Not Recruiting

Avelumab Program Rollover Study

NCT03815643

Conditions
Adenocarcinoma, Adnexal Diseases, Bronchial Neoplasms, +32 more
Locations
  • HonorHealth Research Institute Scottsdale, Arizona, United States
  • Highlands Oncology Group Fayetteville, Arkansas, United States
  • University of California Davis Health System - Comprehensive Cancer Center Sacramento, California, United States
  • Providence Medical Foundation Santa Rosa, California, United States
View all 104 locations
View Trial Details
Active, Not Recruiting

First Line Treatment With Olaparib in Combination With Bevacizumab in HRD Positive Patients

NCT06121401

Conditions
Adnexal Diseases, Carcinoma, Carcinoma, Ovarian Epithelial, +16 more
Locations
  • Azienda Socio Sanitaria Territoriale (ASST) Lariana San Fermo della Battaglia, Como, Italy
  • Spedali Civili Brescia, Italy
  • Policlinico Careggi Florence, Italy
  • Ospedale Manzoni Lecco, Italy
View all 14 locations
View Trial Details
Active, Not Recruiting

A Study of Olaparib Prior to Surgery and Chemotherapy in Ovarian, Primary Peritoneal, and Fallopian Tube Cancer

NCT02489006

Conditions
Adnexal Diseases, Debulking Surgical Procedures, Endocrine Gland Neoplasms, +18 more
Locations
  • Tom Baker Cancer Centre Calgary, Alberta, Canada
  • Ottawa Regional Cancer Centre Ottawa, Ontario, Canada
  • Princess Margaret Cancer Centre Toronto, Ontario, Canada
  • Centre hospitalier de l'Université de Montréal (CHUM Montreal, Quebec, Canada
View Trial Details
Active, Not Recruiting

A Study of TRK-950 in Combinations With Anti-Cancer Treatment Regimens in Patients With Advanced Solid Tumors

NCT03872947

Conditions
Adenocarcinoma, Adnexal Diseases, Bladder Cancer, +58 more
Locations
  • HonorHealth Research Institute Scottsdale, Arizona, United States
  • AOA-HOPE Tucson, Arizona, United States
  • USC Norris Comprehensive Cancer Center Los Angeles, California, United States
  • HOAG Memorial Hospital Presbyterian Newport, California, United States
View all 14 locations
View Trial Details

Related conditions